Search Press releases Keywords From To 16 Jan 2019 UCB and Amgen Receive Positive Vote From FDA Advisory Committee In Favor of Approval For EVENITY™ (Romosozumab) Read More 8 Jan 2019 EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of Osteoporosis In Patients at High Risk of Fracture Read More 8 Jan 2019 Transparency notification UCB SA/NV Read More Pagination First page Previous page Previous … Page 66 Page 67 Page 68 Page 69 Page 70 Page 71 Page 72 Page 73 Current page 74 Page 74 of 74 Stay up-to-date on the latest news and information from UCB Subscribe
